Growth Metrics

Aurinia Pharmaceuticals (AUPH) Change in Acquisitions & Divestments (2018 - 2025)

Historic Change in Acquisitions & Divestments for Aurinia Pharmaceuticals (AUPH) over the last 9 years, with Q3 2025 value amounting to $93.5 million.

  • Aurinia Pharmaceuticals' Change in Acquisitions & Divestments fell 2947.18% to $93.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $472.8 million, marking a year-over-year decrease of 2114.67%. This contributed to the annual value of $585.4 million for FY2024, which is 1058.64% up from last year.
  • Aurinia Pharmaceuticals' Change in Acquisitions & Divestments amounted to $93.5 million in Q3 2025, which was down 2947.18% from $132.2 million recorded in Q2 2025.
  • In the past 5 years, Aurinia Pharmaceuticals' Change in Acquisitions & Divestments ranged from a high of $170.5 million in Q1 2024 and a low of $60.9 million during Q1 2021
  • For the 5-year period, Aurinia Pharmaceuticals' Change in Acquisitions & Divestments averaged around $121.0 million, with its median value being $120.5 million (2022).
  • Per our database at Business Quant, Aurinia Pharmaceuticals' Change in Acquisitions & Divestments soared by 8143.42% in 2022 and then plummeted by 2947.18% in 2025.
  • Quarter analysis of 5 years shows Aurinia Pharmaceuticals' Change in Acquisitions & Divestments stood at $90.7 million in 2021, then skyrocketed by 30.36% to $118.2 million in 2022, then increased by 16.82% to $138.1 million in 2023, then dropped by 10.22% to $124.0 million in 2024, then dropped by 24.58% to $93.5 million in 2025.
  • Its Change in Acquisitions & Divestments was $93.5 million in Q3 2025, compared to $132.2 million in Q2 2025 and $123.0 million in Q1 2025.